Article Information
History
- July 30, 2020.
Article Versions
- Version 1 (July 13, 2020 - 15:42).
- You are currently viewing Version 2 of this article (July 30, 2020 - 16:42).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Robert J Edwards1,2,‡,*,
- Katayoun Mansouri1,‡,
- Victoria Stalls1,‡,
- Kartik Manne1,‡,
- Brian Watts1,
- Rob Parks1,
- Katarzyna Janowska1,
- Sophie M. C. Gobeil1,
- Dapeng Li1,
- Xiaozhi Lu1,
- Margaret Deyton1,
- Jordan Sprenz1,
- Wilton Williams1,2,
- Kevin Saunders1,3,
- Gregory D. Sempowski1,
- Rory Henderson1,2,
- Munir Alam1,2,
- Barton F. Haynes1,2 and
- Priyamvada Acharya1,3,*
- 1Duke Human Vaccine Institute, Durham NC 27710, USA
- 2Duke University, Department of Medicine, Durham NC 27710, USA
- 3Duke University, Department of Surgery, Durham NC 27710, USA
- 4Duke University, Department of Immunology, Durham NC 27710, USA
- ↵*To whom correspondence should be addressed Correspondence to: Robert J Edwards (rj.edwards{at}duke.edu) and Priyamvada Acharya (priyamvada.acharya{at}duke.edu)
↵‡ These authors contributed equally.